The use of multicolor fluorescence technologies in the characterization of prostate carcinoma cell lines
- 1 January 2001
- journal article
- research article
- Published by Elsevier in Cancer Genetics and Cytogenetics
- Vol. 124 (2) , 112-121
- https://doi.org/10.1016/s0165-4608(00)00339-3
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Chemotherapy for advanced hormone refractory prostate cancerUrology, 1999
- Assessment of Chromosomal Trisomies in Prostate Cancer Using Fluorescent in Situ HybridizationExperimental and Molecular Pathology, 1999
- LOSS OF HETEROZYGOSITY ON CHROMOSOME 13 IS ASSOCIATED WITH ADVANCED STAGE PROSTATE CANCERJournal of Urology, 1999
- CHROMOSOME 16 ALLELIC LOSS ANALYSIS OF A LARGE SET OF MICRODISSECTED PROSTATE CARCINOMASJournal of Urology, 1999
- Loss of heterozygosity at chromosome arm 13q and RB1 status in human prostate cancerHuman Pathology, 1999
- Genetic alterations in prostate cancer cell lines detected by comparative genomic hybridizationCancer Genetics and Cytogenetics, 1998
- Retinoblastoma gene mutations in primary human prostate cancerThe Prostate, 1995
- Tumor suppressor gene P53 mutations in human prostate cancerThe Prostate, 1995
- Evaluation of 20 archival prostate tumor specimens by fluorescence in situ hybridization (FISH)Cancer Genetics and Cytogenetics, 1994
- Enhanced expression of the c‐myc protooncogene in high‐grade human prostate cancersThe Prostate, 1987